News

Announcements & milestones.

Partnerships, hires, financings, and platform releases from the Verge Labs team.

2025

Clinical · ALS · Biomarkers April 7, 2025

Digital biomarkers detect short-term ALS progression in VRG50635 trial run-in

By Verge Genomics

2024

Partnerships · Pipeline · ALS November 20, 2024

Lilly selects two ALS targets from CONVERGE® collaboration

By Verge Genomics

2023

Clinical · ALS · Pipeline November 29, 2023

VRG50635 proof-of-concept study initiated in patients with ALS

By Verge Genomics
Partnerships · Neuropsychiatry October 31, 2023

Verge Genomics and the Pritzker Consortium form schizophrenia research collaboration

By Verge Genomics
Partnerships · Pipeline · Rare Disease September 8, 2023

Verge Genomics and Alexion launch AI-enabled drug discovery collaboration for rare neuro diseases

By Verge Genomics
Clinical · ALS · Pipeline June 15, 2023

Positive Phase 1 safety and tolerability data for VRG50635

By Verge Genomics

2022

2021

Partnerships · Pipeline · ALS July 8, 2021

Verge Genomics and Eli Lilly announce three-year ALS collaboration

By Verge Genomics

2020

Platform · Publication October 5, 2020

New approach for uncovering novel drug targets from human genetics published in PLOS Computational Biology

By Verge Genomics